ArticleBMC microbiology2026
Genome-to-function integrated exploration of polyethylene biodegradation by Rhodococcus opacus R7.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPolyethylene (PE) is the most widely produced polyolefin and represents a major contributor to plastic waste, largely due to its chemical stability and resistance to biological degradation. PE biodegradation is typically characterized as a series of oxidative metabolic processes rather than mineralization. An urgent priority is the development of integrated experimental setups that bring together physiological, biochemical, and molecular analyses under controlled cultivation conditions to unlock the metabolic traits of PE biodegradation. This study aims to elucidate the molecular mechanisms of commercial low-molecular-weight PE (LDPE) attack by Rhodococcus opacus R7 through an integrated genome-to-function approach, including growth and extracellular laccase assays, intracellular lipid quantification, gas chromatography coupled with mass spectrometry (GC-MS) analysis of compounds associated with untreated LDPE, and transcriptional profiling of oxidative enzymes.
resultsLDPE utilization was evaluated under multiple cultivation strategies (1% single-dose vs. 0.4% fed-batch), inoculum conditions, and polymer types (untreated or UV-pretreated) over 28 days. Fed-batch LDPE (0.4%) supported slightly higher viable cell numbers than fixed-dose LDPE (1%), while prolonged PE pre-adaptation did not enhance growth. Extracellular laccase activity was detected under all conditions, but was more influenced by the physiological status of the inoculum than by PE concentration or pretreatment. Lipid accumulation was early detected in case of 1% PE, while the fed-batch conditions reflected the growth phase and physiological responses. GC-MS analyses revealed that LDPE oxidation products vary compared to abiotic and control samples. Specifically, fixed-dose LDPE favored a progressive change in the pattern-profile of carboxylic acids and medium- to long-chain alkanes, while fed-batch LDPE produced a heterogeneous mixture, including alcohols and ketones, consistent with a continuous and asynchronous transformation of the polymer. The fed-batch condition induced a broader and earlier transcriptional activation of oxidative genes, including seven laccase-like multicopper oxidases (LMCOs), alkane monooxygenase (alkB), benzoate dioxygenase (benA), and cytochrome P450 hydroxylase. Long-chain n-alkanes, particularly tetracosane (C24), strongly induced oxidative enzymes, suggesting their role as metabolic signals during PE degradation.
conclusionsOverall, LDPE attack by R. opacus R7 emerges as a dynamic process shaped by substrate accessibility and cultivation strategy, highlighting its potential as a platform for controlled plastic biodegradation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.